Albert W Brzeczko insider trades: Acura Pharmaceuticals (ACUR) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Albert reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 14, 2017 | ACUR | ↑ Buy | 300,000 | $0.10 | $30K | Direct | Dec 15, 2017 (1d) |
| Aug 29, 2017 | ACUR | ↑ Buy | 10,800 | $0.47 | $5K | Direct | Aug 29, 2017 (0d) |
| May 19, 2014 | ACUR | ↑ Buy | 2,000 | $1.20 | $2K | Direct | May 19, 2014 (0d) |
| Nov 25, 2013 | ACUR | ↑ Buy | 1,215 | $1.70 | $2K | Direct | Nov 26, 2013 (1d) |
| May 18, 2012 | ACUR | ↑ Buy | 1,000 | $2.55 | $3K | Direct | May 18, 2012 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Albert W Brzeczko's insider trades
Albert W Brzeczko is See Remarks at Acura Pharmaceuticals (ACUR). Since May 18, 2012, Albert has reported 5 open-market purchases worth $42K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), option exercises (5 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACUR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.